Preložnik Navodnik, M.; Reberšek, K.; Klinar, K.; Janež, A.; Podgornik, H.
Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus. Curr. Issues Mol. Biol. 2025, 47, 54.
https://doi.org/10.3390/cimb47010054
AMA Style
Preložnik Navodnik M, Reberšek K, Klinar K, Janež A, Podgornik H.
Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus. Current Issues in Molecular Biology. 2025; 47(1):54.
https://doi.org/10.3390/cimb47010054
Chicago/Turabian Style
Preložnik Navodnik, Maja, Katarina Reberšek, Katarina Klinar, Andrej Janež, and Helena Podgornik.
2025. "Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus" Current Issues in Molecular Biology 47, no. 1: 54.
https://doi.org/10.3390/cimb47010054
APA Style
Preložnik Navodnik, M., Reberšek, K., Klinar, K., Janež, A., & Podgornik, H.
(2025). Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus. Current Issues in Molecular Biology, 47(1), 54.
https://doi.org/10.3390/cimb47010054
_Kim.png)
